- cafead   Oct 10, 2021 at 10:02: PM
via
article source
- Vaxart is launching a phase 2 trial for its vaccine candidate this month.
- The Vaxart candidate showed reduced airborne transmission of the virus in an animal study.
- Vaxart could launch a vaccine post-pandemic if all goes smoothly.
article source